previoUs Knowledge
In 1968, Cooper et al. provided the first evidence of PCOS being a genetically predisposed disorder. [7] Several small-family studies confirmed this hypothesis, and it was found that the prevalence of PCOS ranged from 51% to 66% among the first-degree relatives of the probands. [8, 9] Studies on the incidence of PCOS in twins have confirmed that some of its symptoms are hereditary; [10] however, PCOS does not demonstrate clear Mendelian inheritance and is considered to be a complex trait. [11] Due to differences in the results, it was difficult to confirm whether PCOS is a disease characterized by dominant autosomal inheritance, but both studies confirmed that it is an X-linked disorder. [10] [11] [12] These findings confirm that differences in the clinical manifestations of the disorder among patients may have a genetic basis, and the phenomenon of familial aggregation in PCOS has aroused the interest of scholars in studying its genetic attributes at a molecular level. As PCOS is a polygenic disease, the current research on candidate genes involves genes related to sex hormones and gonadotropins, insulin, hyperandrogenism, and chronic inflammatory factors. [13] whAt wAs discovered in genome-wide AssociAtion stUdies?
Genes associated with steroidogenesis, sex hormones, and their receptors are considered to be the essential candidates of PCOS due to their roles in folliculogenesis. These genes mainly include CYP11A1, CYP17A, CYP19, CYP21, HSD17B5, HSD17B6, those of the androgen receptor (AR), SHBG, FSH, FSHR, and LHCGR. [14] In the past, many studies depended on the assumption that candidate genes provide limited scope for statistical analysis due to inadequate sample sizes. [14] Surprisingly, the impact of sample sizes was reduced by the wide use of GWAS in the research of PCOS. From the time that the application of GWAS was first reported till now, in Han, five GWAS were conducted on female populations with PCOS belonging to the Chinese, [15, 16] Korean, [17] and European ancestries. [18, 19] In total, 16 robust loci were identified (P < 5 × 10 −8 [19] However, only few loci have been discovered in both GWAS that may suggest the involvement of ethnic differences. We also found that the diagnostic criteria used by the authors were not very consistent. Surprisingly, recent findings suggest little influence of genetic heterogeneity between the diagnostic criteria at the identified risk loci. [20] Although significant progress had been made in the past, considerable amount of work remains to be conducted to fully understand the pathogenesis of PCOS. Importantly, although GWAS were commonly employed to analyze the correlation between DNA polymorphisms and specific traits of the disease, they do not pinpoint the causal variants, regulatory elements, or genes responsible for these association signals. [20] Finally, studies have been conducted in the "post-GWAS" era, in which interpretation of the functional effects of individual genetic variations that confer susceptibility to PCOS is a major challenge for the researchers.
Genotype-phenotype correlations based on genome-wide association studies
The influence of single-nucleotide polymorphisms (SNPs) identified in the previous GWAS on specific subtypes and their role in the pathogenesis of PCOS remain unknown. To determine this, a cross-sectional study involving 1,731 patients with PCOS and 4,964 controls was conducted. Finally, the researchers found that the SNPs in THADA and DENND1A were associated with the subtypes of PCOS, whereas the probability of the involvement of LHCGR (rs13405728) in oligo-or anovulation was higher. Besides, the rs13429458 AA genotype in the THADA gene and GG and GA groups of rs2479106 in the DENNDIA gene were considered to be significantly risky genotypes which were involved in the manifestation of hyperandrogenemia (HA) and IR in PCOS, respectively. [21] These results have inspired researchers to conduct functional studies further which may help in the identification of individuals most likely to respond to specific targeted therapies. Similarly, researchers had adopted methods used in the GWAS to gather information on SNPs that may be associated with PCOS. Three SNP sites containing significantly different allele frequencies between the patient and control groups (P < 0.05) were found. They are as follows: rs346795081 on THADA, rs346803513 on DENND1A, and rs346999236 on TOX3. [22] However, the sample size of several subgenotype groups was low (n < 4), which decreased the credibility of the results. Therefore, further studies should focus on involving women from different genetic backgrounds and elaborate on genetic functions associated with the etiological mechanisms of PCOS phenotypes. Finally, the attributes of PCOS vary depending on the phenotypes. The metabolic features available in literature suggest that the specific subtypes should be focused upon. [23] Interestingly, different subphenotypes are associated with genotypes demonstrating different risk attributes, [24] and studies conducted on them may present new insights for the personalized diagnosis and treatment of PCOS in future.
Analysis of the genome-wide association studies-based pathways involved in polycystic ovary syndrome
The pathway-based approach integrates the results of GWAS with those of the studies involving genes associated with biological pathways or gene sets from predefined human databases, which could improve on the limitations of the GWAS in determining biological functions. Moreover, analysis of the GWAS-based pathways helps in the identification of additional risk factors with moderate statistical significance. [24] Several studies had applied post-GWAS analysis to the GWAS dataset of patients with PCOS and identified significant pathways involved in ovulation and insulin secretion. INS, GNAQ, STXBP1, PLCB3, PLCB2, SMC3, and PLCZ1 were the important genes involved in the induction and regulation of these biological pathways (P values of all the genes were <0.05). [25] In conclusion, it can be stated that, by applying pathway analysis to a GWAS dataset, it is possible to understand the mechanisms underlying PCOS better.
other genes AssociAted with polycystic ovAry syndrome

Sex hormones and gonadotropin-related genes
Hyperandrogenism is an important endocrine disorder found in patients with PCOS, which also helps in its diagnosis. Elevated levels of androgens in the ovary and blood circulation can inhibit the development and maturation of ovarian follicles, resulting in anovulation, hypertrichosis, acne, and a number of other clinical manifestations. Studies have found that heredity and variation are mainly linked to hyperandrogenism in patients with PCOS, whereas other factors account only for 5%-10% of the symptoms. [26] MicroRNA (miRNA) is a single small noncoding RNA with a length of about 22 nucleotides. It was found that miRNA changes the structure of the target genes or chromosomes and affects separation and transcription, resulting in conditions such as restructuring, mutation, and changes in the cell cycle. [27, 28] Furthermore, because the development of 60% of diseases associated with the human body is dependent on the efficiency of protein coding, it was recently determined that the miRNA can be used as a biomarker for the diagnosis and prognosis of a wide range of diseases including cancer and cardiovascular diseases. Studies have tried to link miRNA to the occurrence of HAin patients with PCOS. When the follicular fluid of patients with PCOS demonstrating HA as well as that of normal females was analyzed, 236 miRNAs were found to be significantly different in the experimental group and 7 in the control group, which are as follows: 200a-3p, 10b-3P, 200b-3p, 29c-3p, 99a-3p, 125a-5p, and 105-3p. It has been confirmed previously that miRNAs are involved in the manifestation of HA in patients with PCOS. Although a significant rise in their levels was observed, their exact mechanism of inducing HA was unclear. Using gene ontology analysis, it was speculated that these 263 miRNAs were related to 31,770 genes, which were mainly involved in the apoptosis and insulin receptor signaling, [29] indicating the possible relationship between HA-related genes and PCOS. For example, there are researchers which have found that overexpressed DENND1A could increase CYP17A1 and CYP11A1 gene transcription, mRNA abundance, and androgen biosynthesis, and thus resulted in a PCOS phenotype. [30] What is more, CAPN 10 gene UCSNP-43 polymorphism may play a role in PCOS's HA due to the association with increased D4 androstenedione. [31] In future, we should focus on the specific mechanism of more genetic action in order to better understand this disease.
Genes associated with luteinizing hormone
In PCOS, changes occurring in the gonadotropins were mainly manifested as an increase in the levels of luteinizing hormone (LH), normal or decreased levels of follicle-stimulating hormone (FSH), and an increased LH/FSH ratio. In a recent study conducted to confirm the susceptibility of two other loci in the Han population, it was found that the FSHB gene was associated with an increased susceptibility to PCOS and an increase in the levels of LH in the Han population. In addition, it was determined that the high-risk allele A for PCOS in the FSHB variant rs11031010 was closely related to the presence of high amounts of LH. Studies have found that increased levels of LH induce an increased production of androgen T by cells in the ovarian membranes which can regulate the process of gonadotropin production by the hypothalamus through a feedback mechanism, [18] which may explain the high levels of LH associated with the functioning of the FSHB gene.
Genes associated with follicle-stimulating hormone receptor
The FSH plays an important role in follicular growth, maturation, and generation of steroid hormones via the involvement of the FSHR. One of the characteristics of PCOS is the failure of follicular growth. Therefore, it can be suggested that the FSHR gene is likely to play a crucial role in the pathogenesis of PCOS. The FSHR gene is located on chromosome 2p21, and includes 10 exons and 9 introns, with very few variants. Only two variants have been identified so far, which are as follows: p. Thr307Ala (c.919A > G, rs6165) and p. Asn680Ser (c.2039A > G, rs6166). In the latest study on women belonging to Korean origin, a significant correlation between p. Thr307Ala (c.919A > G, rs6165), p. Asn680Ser (c.2039A > G, rs6166), and PCOS was found. [32] However, it failed to explain their causal relationship and hence, further studies are needed for its determination. However, the results of previous studies on the susceptibility of the variant and PCOS are not consistent, [18] which may be due to the differences among the races.
Genes involved in metabolism: Insulin-related genes
One of the main manifestations of PCOS is IR and hyperinsulinemia, which can be associated with the probability of the corresponding genes playing a role in its pathogenesis. Many genetic mutations lead to IR and T2DM, of which, involvement of the transcription factor gene (TCF7L2) only has been clearly identified. TCF7L2 on chromosome 10 q25. 2 influences multiple gene transcriptions. It has been confirmed that in different ethnicities, TCF7L2 acts as the promoter for suppression and transactivation of genes by mediating the Wnt signaling pathways, which play a different role in the activation of islet cells. [33] Some scholars have analyzed the relationship between the susceptibility of the SNP rs7903146 and PCOS, which is very closely related to the occurrence of T2M by the involvement of TCF7L2. However, in a previous study, different results showing the genotypic variants CC, CT, and TT in TCF7L2 were found. [34] Besides, thyroid adenoma-associated gene (THADA) was also found to play an important role in the regulation of pancreatic beta-cell function which could lead to IR. [35] However, in the study involving the gene TCF7L2, the results were not consistent because different sample sizes yielded different results, suggesting that further studies with larger sample sizes are needed to obtain more accurate conclusions.
Other discoveries
Genes associated with pro-inflammatory response factors such as tumor necrosis factor-α The imbalance of pro-inflammatory/anti-inflammatory cytokines has become a key factor in immunity, in which, tumor necrosis factor (TNF) activation plays an important role. TNF-α is secreted by ovarian macrophages, granular luteal cells, and immune cells. It is coded by a gene on the chromosome 6P21.3 and has a promoter of 1,100 bp length. [34] Replacement of nucleotides in this region can affect the binding affinity of the transcription factors, thus affecting the expression levels of the genes. Therefore, different concentrations of serum TNF-α are produced, resulting in the occurrence of a variety of diseases. In addition to interfering with the immune and inflammatory responses, differentiation, proliferation, and apoptosis, previous studies have also found that the production of TNF-α is associated with obesity, IR, and HA in patients with PCOS. In patients with POCS, the production of TNF-α in the granulocytes has been found to reduce the expression of the aromatase gene. This process leads to a decrease in the production of 17-β-estradiol in the ovary by inhibiting the induction of adenosine cyclase and cyclic phosphate signaling pathways, resulting in an increase in the levels of ovarian androgens indirectly. [36] In addition, TNF-α was also found to induce serine phosphorylation in the insulin receptor substrate 1, leading to an inhibition of the activity of the insulin receptor tyrosine kinase that consequently results in IR and hyperinsulinemia. [36] Thus, TNF-α may indirectly lead to the development of PCOS.
MicroRNAs
MiRNAs are small noncoding RNA molecules that regulate gene expression posttranscriptionally by interacting with the mRNAs, particularly at 3' untranslated region. [27] miRNAs have received increasing attention in recent studies because it is believed that a dysregulation in their expression may result in the occurrence of disorder during folliculogenesis and reduction in the ovulation rate, which are the main characteristics of PCOS. Moreover, as the miRNA functions by employing complementary sequences, hundreds of mRNAs could be targeted by a single miRNA molecule, which makes them potential biomarkers of PCOS. [37] Naji et al. found that, compared to the mormo-androgenic individuals, miR-93 and miR-21 were present at significantly higher levels in the granulosa cells (GCs) of patients with HA, whereas a decrease in the levels of the follicular fluid and no changes in their serum samples were observed. [38] However, the sample size (n < 40) of this study was relatively small, which reduced the credibility of the results. Despite this limitation, a potential role of miRNAs in the molecular mechanism of the GCs has been indicated. Further studies should be conducted to elaborate on the specific role of miRNAs in the pathogenesis of PCOS.
Mitochondrial DNA hypermethylation
Studies have found that, in individuals with POCS, the number of mitochondria greatly increased in the oocytes and played critical roles during oocyte maturation and fertilization, which are the main characteristics of PCOS. Therefore, we can elucidate the presence of some association between them. The primary function of the mitochondrion is the production of ATP via the oxidative phosphorylation (OXPHOS) pathway. Mammalian mitochondrial DNA (mtDNA) is approximately 16 kb in size and encodes 13 proteins which are subunits of the OXPHOS complexes, 22 transfer RNAs, and 2 ribosomal RNAs. mtDNA was found to be involved in epigenetic modifications and can, thus, contribute to mitochondrial dysfunction. [39] Although mtDNA has not been researched as thoroughly as nuclear DNA, its association and role in the occurrence of PCOS were first studied by Jia et al. They used cross-bred prepubertal gilts as experimental subjects. Interestingly, they found that the hypermethylation of mtDNA is associated with mitochondrial malfunction and poor quality of oocytes derived from the polycystic ovaries of the gilts. Although these findings were obtained mainly from association analysis and lacked information from a human-based experiment with a large sample size, it still provides a new insight to the pathogenesis of PCOS. [40] Genes associated with fat mass obesity (FTO) Obesity is a common feature of PCOS, and the obesity rate of patients with PCOS is approximately 50%. [41, 42] FTO is located on chromosome 16q12.2, which has been associated with body mass index, weight gain, T2DM, inflammation, and other factors in different populations. [43] These are common clinical features of PCOS, and hence, it can be assumed that FTO, which is related to fat content and obesity, may also be one of the susceptible genes involved in the occurrence of PCOS. In a study in which the relationship between FTO (rs9926289A/G, rs79206939A/G, rs8050136A/T, and rs9930506A/G) and PCOS was evaluated, it was found that SNPs in the FTO rs8050136A/C and rs1588413C/T were associated with susceptibility to PCOS and people with the susceptibility gene were more likely to be obese. Among these, rs8050136 A may be a risk allele for PCOS, and rs8050136 and rs1588413 were also found to be associated with the follicular number and embryo transfer rate, respectively. [43] The correlation between FTO and PCOS has been suggested, but further studies are needed to determine the specific relationship between the FTO gene and PCOS.
conclUsions
In this article, we have summarized the recent progress in research associated with PCOS. Despite new findings, there are no genes or biomarkers that can be used singularly as exact indicators for the diagnosis of PCOS. Furthermore, information on the genes responsible for PCOS susceptibility is often controversial in some respect, and no effective methods are available to predict those involved in the occurrence of PCOS. Not only genetic factors but epigenetics, environment, and other attributes also affect the pathogenesis of PCOS. Besides, this review was limited to incomplete literature collection, and some studies that were published at the time of writing have not been included. However, we can conclude that some new insights related to PCOS have been found in recent years. More importantly, there is still a long way to go before we can fully understand the pathogenesis of PCOS and apply the suggested therapies clinically to improve the life of women.
